Lumigan 0.01%

Lumigan 0.01%





Concise Prescribing Info
Reduction of elevated IOP in patients w/ open-angle glaucoma or ocular HTN intolerant of or insufficiently responsive to other IOP-lowering medications.
Dosage/Direction for Use
1 drop in the affected eye(s) at max of once daily in the evening.
Special Precautions
Increased risk of pigmentation of the iris, periorbital tissue & eyelash changes. Active intraocular inflammation (eg, uveitis); aphakia, pseudophakia w/ a torn posterior lens capsule, patients w/ known risk factors for macular edema; bacterial keratitis; hepatic impairment. Remove contact lens prior to administration & reinsert 15 min after. Pregnancy & lactation. Childn <16 yr.
Adverse Reactions
Conjunctival hyperemia. Growth of eyelashes, ocular pruritus, ocular dryness, visual disturbance, ocular burning, foreign body sensation, eye pain, pigmentation of the periocular skin, blepharitis, cataract, superficial punctate keratitis, eyelid erythema & pruritus, ocular irritation, eyelash darkening; hypertrichosis, instillation site irritation, skin hyperpigmentation. Systemic effects eg, colds & upper resp infection, headache, abnormal liver function tests, asthenia & hirsutism.
MIMS Class
Antiglaucoma Preparations
ATC Classification
S01EE03 - bimatoprost ; Belongs to the class of prostaglandin analogues. Used in the treatment of glaucoma and hypotrichosis of the eyelashes.
Lumigan 0.01% ophth soln 0.01%
3 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in